*** GET YOUR TICKETS AT http://cannagather.com/september2019 ***
Join us for Dinner, Drinks, Networking, Education, and More!
Dinner, Drinks, and introductions
News Updates, Announcements
Keynote Speakers, Q&A
Giveaways & Networking
Chair, New York Medical Cannabis Industry Association
VP Corporate Affairs, Columbia Care LLC
Adam serves as Chairperson of the New York Medical Cannabis Industry Association. In that role Adam helps advance the Association's mission of protecting and serving the patients in New York’s medical marijuana program while leading the way for proposed adult-use legalization across the state. NYMCIA is comprised of the leading manufacturers in the state: Citiva, Columbia Care, CrescoLabs, PharmaCann, The Botanist and Acreage NY, and Vireo Health.
Adam is the VP of Corporate Affairs of Columbia Care and helps develop new market opportunities and leads their public affairs communications and external affairs activities. Columbia Care operates one of the largest portfolios (14 U.S. states/jurisdictions + the EU) of highly regulated, licensed medical cannabis product development, research, manufacturing and dispensing operations in the United States. The company produces industry leading pharmaceutical quality products and has research and clinical partnerships with top academic and medical institutions including; Columbia University, the Dana-Farber Cancer Institute and Mount Sinai Hospital.
Adam was a long-time Senior Advisor to then Governor O’Malley of Maryland as well as a Advisor to the Democratic Governors Association. Amongst others, he worked for then Governor Tim Kaine and Senator Hillary Clinton.
Adam earned an MBA from The Wharton School at The University of Pennsylvania and received his B.A. in Political Science and Economics from Colorado State University. He is passionate about history and is an appointee of Governor Terry McAuliffe to the Virginia State Historical Records Board. He lives in New York City.
Dr. David Nathan
President, Doctors for Cannabis Regulation
David L. Nathan, MD, DFAPA is a Princeton, New Jersey based psychiatrist, educator and consultant, working exclusively through Princeton Psychiatry & Consulting, LLC. He is also a professional speaker and published author on diverse topics in medicine, academia and social justice.
Originally from the Philadelphia area, Dr. Nathan graduated magna cum laude from Princeton University. He received his M.D. from the University of Pennsylvania School of Medicine, where he distinguished himself in the development of medical education software. He subsequently entered the McLean Hospital Residency Training Program of Harvard Medical School. In his final year at McLean, Dr. Nathan served as Chief Resident of the Bipolar and Psychotic Disorders Program. In this capacity, he supervised residents on the inpatient service and founded an outpatient clinic with senior clinicians and residents.
Dr. Nathan is a leading advocate for evidence-based changes in drug policy, focusing on principles of public health and social justice. Please note that Dr. Nathan’s views on drug policy do not necessarily reflect those of PHCS, PHBH, or RWJMS. He has published numerous articles on the subject for local, national and international news outlets. In 2014 he was appointed to the steering committee of New Jersey United for Marijuana Reform (NJUMR), which is a coalition of the New Jersey chapters of the ACLU, NAACP and other organizations. He is the founder and Board President of Doctors for Cannabis Regulation (DFCR), the first and only national and international physicians’ organization dedicated to the legalization, regulation and taxation of marijuana. He was the main author of DFCR’s founding document, “A Declaration of Principles,” which was published when the organization launched in April 2016.